A. Battle, S. Mostafavi, X. Zhu, J. B. Potash, M. M. Weissman et al., Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals, Genome Research, vol.24, pp.14-24, 2014.

Y. Lu, D. B. Goldstein, M. Angrist, and G. Cavalleri, Personalized Medicine and Human Genetic Diversity. Cold Spring Harb Perspect Med, vol.4, pp.8581-8582, 2014.

W. E. Evans, Pharmacogenomics: translating functional genomics into rational therapeutics, 1999.

S. Rousseaux, A. Debernardi, B. Jacquiau, A. Vitte, A. Vesin et al., Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers, Sci Transl Med. American Association for the Advancement of Science, vol.5, pp.186-66, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01261754

M. S. Lawrence, P. Stojanov, C. H. Mermel, J. T. Robinson, L. A. Garraway et al., Discovery and saturation analysis of cancer genes across 21 tumour types, Nature, vol.505, pp.495-501, 2014.

K. A. Hoadley, C. Yau, D. M. Wolf, A. D. Cherniack, D. Tamborero et al., Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin, Cell, vol.158, pp.929-973, 2014.

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.25516281, 2014.

M. D. Robinson, D. J. Mccarthy, and G. K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, vol.26, pp.139-179, 2010.

M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Research, vol.43, pp.47-54, 2015.

D. M. Mutch, A. Berger, R. Mansourian, A. Rytz, and M. Roberts, The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data, BMC Bioinformatics. BioMed Central, vol.3, p.17, 2002.

W. Goh, W. Wang, and L. Wong, Why Batch Effects Matter in Omics Data, and How to Avoid Them, Trends in Biotechnology. Elsevier Current Trends, vol.35, pp.498-507, 2017.

C. Evans, J. Hardin, and D. M. Stoebel, Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions, Briefings in Bioinformatics, vol.19, pp.776-92, 2018.

P. Li, Y. Piao, H. S. Shon, and K. H. Ryu, Comparing the normalization methods for the differential analysis of Illumina high-throughput RNA-Seq data, BMC Bioinformatics. BioMed Central, vol.16, p.347, 2015.

F. Vitali, Q. Li, A. G. Schissler, J. Berghout, C. Kenost et al., Developing a "personalome" for precision medicine: emerging methods that compute interpretable effect sizes from single-subject transcriptomes, Briefings in Bioinformatics, vol.63, p.2889, 2017.

H. Wang, Q. Sun, W. Zhao, L. Qi, Y. Gu et al., Individual-level analysis of differential expression of genes and pathways for personalized medicine, Bioinformatics, vol.31, pp.62-70, 2015.

X. Li, H. Cai, X. Wang, L. Ao, Y. Guo et al., A rank-based algorithm of differential expression analysis for small cell line data with statistical control, Briefings in Bioinformatics, vol.20, pp.482-91, 2019.

Q. Guan, R. Chen, H. Yan, H. Cai, Y. Guo et al., Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms, Oncotarget, vol.7, pp.68909-68929, 2016.

L. Qi, L. Chen, Y. Li, Y. Qin, R. Pan et al., Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer, Briefings in Bioinformatics, vol.17, pp.233-275, 2016.

X. Zhou, B. Li, Y. Zhang, Y. Gu, B. Chen et al., A relative ordering-based predictor for tamoxifentreated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation, Breast Cancer Res. Treat, vol.142, p.24253811, 2013.

L. Wang, Z. Feng, X. Wang, X. Wang, and X. Zhang, DEGseq: an R package for identifying differentially expressed genes from RNA-seq data, Bioinformatics, vol.26, pp.136-144, 2010.

S. Tarazona, P. Furió-tarí, D. Turrà, A. D. Pietro, M. J. Nueda et al., Data quality aware analysis of differential expression in RNA-seq with NOISeq R/Bioc package, Nucleic Acids Research, vol.43, p.140, 2015.

J. Feng, C. A. Meyer, Q. Wang, J. S. Liu, S. Liu et al., GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data, Bioinformatics, vol.28, pp.2782-2790, 2012.

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, Cancer Journal for Clinicians, vol.69, pp.7-34, 2019.

, Comprehensive molecular profiling of lung adenocarcinoma, Nature, vol.511, pp.543-50, 2014.

, Comprehensive genomic characterization of squamous cell lung cancers, Nature, vol.489, pp.519-544, 2012.

J. D. Campbell, A. Alexandrov, J. Kim, J. Wala, A. H. Berger et al., Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas, Nat Genet, vol.48, pp.607-623, 2016.

F. Chen, Y. Zhang, E. Parra, J. Rodriguez, C. Behrens et al., Multiplatform-based molecular subtypes of non-small-cell lung cancer, Oncogene, vol.36, pp.1384-93, 2017.

J. Seo, Y. S. Ju, W. Lee, J. Shin, J. K. Lee et al., The transcriptional landscape and mutational profile of lung adenocarcinoma, Genome Research, vol.22, pp.2109-2128, 2012.

U. Testa, G. Castelli, and E. Pelosi, Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells. Cancers (Basel), Multidisciplinary Digital Publishing Institute, vol.10, p.248, 2018.

P. Villalobos and I. I. Wistuba, Lung Cancer Biomarkers, Hematol. Oncol. Clin. North Am, vol.31, pp.13-29, 2017.

H. Tang, S. Wang, G. Xiao, J. Schiller, V. Papadimitrakopoulou et al., Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies, Ann. Oncol, vol.28, pp.733-773, 2017.

M. Shea, D. B. Costa, and D. Rangachari, Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches, Ther Adv Respir Dis. SAGE PublicationsSage UK, vol.10, pp.113-142, 2016.

M. Tsao, S. Marguet, L. Teuff, G. Lantuejoul, S. Shepherd et al., Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection, J. Clin. Oncol. American Society of Clinical Oncology, vol.33, pp.3439-3485, 2015.

W. D. Travis, E. Brambilla, M. Noguchi, A. G. Nicholson, K. R. Geisinger et al., International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma, J Thorac Oncol, vol.6, pp.244-85, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00561753

W. D. Travis, E. Brambilla, A. G. Nicholson, Y. Yatabe, J. Austin et al., The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification, J Thorac Oncol, vol.10, pp.1243-60, 2015.

M. D. Wilkerson, X. Yin, K. A. Hoadley, Y. Liu, M. C. Hayward et al., Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types, Clin. Cancer Res, vol.16, pp.4864-75, 2010.

D. N. Hayes, S. Monti, G. Parmigiani, and C. Clinical, Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts, 2006.

M. Love, S. Anders, and W. Huber, Differential analysis of count data-the DESeq2 package, Genome Biology, 2014.

Z. Chen, C. M. Fillmore, P. S. Hammerman, C. F. Kim, and K. Wong, Non-small-cell lung cancers: a heterogeneous set of diseases, Nat. Rev. Cancer, vol.14, pp.535-581, 2014.

J. George, V. Walter, M. Peifer, L. B. Alexandrov, D. Seidel et al., Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors, Nat Commun, vol.9, p.29535388, 2018.

S. Zhang, M. Li, H. Ji, and Z. Fang, Landscape of transcriptional deregulation in lung cancer, BMC Genomics, vol.19, p.29866045, 2018.

A. J. Bass, H. Watanabe, C. H. Mermel, S. Yu, S. Perner et al., SOX2 is an amplified lineagesurvival oncogene in lung and esophageal squamous cell carcinomas, Nat Genet, vol.41, pp.1238-1280, 2009.

P. P. Massion, P. M. Taflan, S. Rahman, P. Yildiz, Y. Shyr et al., Significance of p63 Amplification and Overexpression in Lung Cancer Development and Prognosis, Cancer Res. American Association for Cancer Research, vol.63, pp.7113-7134, 2003.

N. Mar, J. J. Vredenburgh, and J. S. Wasser, Targeting HER2 in the treatment of non-small cell lung cancer, Lung Cancer, vol.87, pp.220-225, 2015.

E. Shtivelman, T. Hensing, G. R. Simon, P. A. Dennis, G. A. Otterson et al., Molecular pathways and therapeutic targets in lung cancer, Oncotarget. Impact Journals, LLC, vol.5, pp.1392-433, 2014.

A. Kanitz, F. Gypas, A. J. Gruber, A. R. Gruber, G. Martin et al., Comparative assessment of methods for the computational inference of transcript isoform abundance from RNA-seq data, Genome Biol. BioMed Central, vol.16, p.26201343, 2015.

C. Soneson and M. D. Robinson, Bias, robustness and scalability in single-cell differential expression analysis. Nat Meth, Nature Publishing Group, vol.15, pp.255-61, 2018.

Z. Tian, Z. Li, S. Wen, Y. Zhang, Y. Li et al., Identification of Commonly Dysregulated Genes in Non-small-cell Lung Cancer by Integrated Analysis of Microarray Data and qRT-PCR Validation, Lung, vol.193, p.25851596, 2015.

S. A. Macneill, Structure and function of the GINS complex, a key component of the eukaryotic replisome, Biochem. J, vol.425, pp.489-500, 2010.

Y. Nagahama, M. Ueno, S. Miyamoto, E. Morii, T. Minami et al., PSF1, a DNA Replication Factor Expressed Widely in Stem and Progenitor Cells, Drives Tumorigenic and Metastatic Properties, Cancer Res. American Association for Cancer Research, vol.70, pp.1215-1239, 2010.

D. Bertrand, K. R. Chng, F. G. Sherbaf, A. Kiesel, B. Chia et al., Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles, Nucleic Acids Research, vol.43, pp.44-48, 2015.

M. H. Bailey, C. Tokheim, E. Porta-pardo, S. Sengupta, D. Bertrand et al., Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell, vol.173, pp.371-385, 2018.

K. Strimmer, fdrtool: a versatile R package for estimating local and tail area-based false discovery rates, Bioinformatics, vol.24, pp.1461-1463, 2008.

F. Privé, H. Aschard, A. Ziyatdinov, and M. Blum, Efficient analysis of large-scale genome-wide data with two R packages: bigstatsr and bigsnpr, Bioinformatics, vol.34, pp.2781-2788, 2018.

W. Da, . Huang, B. T. Sherman, and R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat Protoc. Nature Publishing Group, vol.4, pp.44-57, 2009.

D. W. Huang, B. T. Sherman, and R. A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Research, vol.37, pp.1-13, 2009.

S. Anders and W. Huber, Differential expression analysis for sequence count data, Genome Biol, vol.11, 2010.